Peter Domaille has joined San Diego-based GeneFormatics as director of structural biolog, the company said last week. Domaille will direct the company’s structural biology programs and NMR development efforts, as well as oversee the company’s collaborations with various Bruker divisions, which are primarily focused on using high-field NMR spectrometers to determine protein structure. He was previously director of biomolecular NMR at DuPont Pharmaceuticals, and has worked at E.I.